Correlation Between AptaBio Therapeutics and Fine Besteel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Fine Besteel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Fine Besteel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Fine Besteel Co, you can compare the effects of market volatilities on AptaBio Therapeutics and Fine Besteel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Fine Besteel. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Fine Besteel.

Diversification Opportunities for AptaBio Therapeutics and Fine Besteel

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between AptaBio and Fine is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Fine Besteel Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fine Besteel and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Fine Besteel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fine Besteel has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Fine Besteel go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Fine Besteel

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Fine Besteel. But the stock apears to be less risky and, when comparing its historical volatility, AptaBio Therapeutics is 1.61 times less risky than Fine Besteel. The stock trades about -0.34 of its potential returns per unit of risk. The Fine Besteel Co is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  85,900  in Fine Besteel Co on August 24, 2024 and sell it today you would earn a total of  19,200  from holding Fine Besteel Co or generate 22.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Fine Besteel Co

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Fine Besteel 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Fine Besteel Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Fine Besteel may actually be approaching a critical reversion point that can send shares even higher in December 2024.

AptaBio Therapeutics and Fine Besteel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Fine Besteel

The main advantage of trading using opposite AptaBio Therapeutics and Fine Besteel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Fine Besteel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fine Besteel will offset losses from the drop in Fine Besteel's long position.
The idea behind AptaBio Therapeutics and Fine Besteel Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals